![Peter M. Allen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Peter M. Allen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
N8 Medical, Inc.
![]() N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Direktor/Vorstandsmitglied | 07.02.2021 | - |
Independent Dir/Board Member | 07.02.2021 | - |
Karriereverlauf von Peter M. Allen
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
N8 Medical, Inc.
![]() N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Health Technology |
- Börse
- Insiders
- Peter M. Allen
- Erfahrung